Company news
Lifecore Biomedical, Inc. (NASDAQ:LFCR) news
Every Lifecore Biomedical, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Lifecore Biomedical to Participate at CPHI Global Conference
September 3, 2026
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
September 2, 2026
Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
August 5, 2026
Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
July 29, 2026
Lifecore Biomedical Signs Three New Customer Agreements
July 28, 2026
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
June 15, 2026
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
June 2, 2026
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
May 21, 2026
Lifecore Biomedical to Participate at CDMO Live Europe
May 12, 2026
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
May 6, 2026
Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026
April 29, 2026
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
April 8, 2026
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
March 26, 2026
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
March 23, 2026
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
March 16, 2026
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
March 10, 2026
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
March 9, 2026
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
March 4, 2026
Lifecore Biomedical to Participate at DCAT Week 2026
February 17, 2026
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
January 19, 2026
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026
Lifecore Biomedical to be Added to Nasdaq Biotech Index
December 18, 2025
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
December 17, 2025
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
December 17, 2025
Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
Lifecore Biomedical to Participate in Upcoming Investor Conferences
November 11, 2025
Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update
November 6, 2025
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025
October 30, 2025
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
October 29, 2025
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
October 28, 2025
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
October 13, 2025
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 23, 2025
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
September 4, 2025
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
August 7, 2025
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025
July 31, 2025
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
June 17, 2025
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
June 12, 2025
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
May 27, 2025
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
April 22, 2025
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
April 14, 2025
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
April 3, 2025
Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025
March 27, 2025
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
March 17, 2025
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
February 26, 2025
Lifecore Biomedical Announces Special Stockholder Meeting
January 17, 2025
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
January 7, 2025
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
January 2, 2025
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
December 19, 2024
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
November 26, 2024
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
November 7, 2024